n 2023, the North American in-vitro colorectal cancer screening tests market reached a valuation of USD 4.2 billion, driven by the increasing prevalence of colorectal cancer across the region. Expected to grow at a CAGR of 7.16% from 2024 to 2032, the market is projected to reach USD 7.9 billion by 2032. This blog will […]

Read More